【结 构 式】 |
【分子编号】38987 【品名】5-bromopyrimidine 【CA登记号】4595-59-9 |
【 分 子 式 】C4H3BrN2 【 分 子 量 】158.9853 【元素组成】C 30.22% H 1.9% Br 50.26% N 17.62% |
合成路线1
该中间体在本合成路线中的序号:(I)Palladium-catalyzed coupling of 5-bromopyrimidine (I) with ethyl acrylate (II) afforded pyrimidinyl acrylate (III), which was hydrogenated over Pd/C to give (IV). Claisen condensation of (IV) with ethyl formate furnished oxoester (V). This was then cyclized with thiourea (VI) to produce the intermediate thiouracil (VII).
【1】 Hickey, D.M.B.; Boyd, H.F.; Flynn, S.T.; et al.; 2-(Alkylthio)pyrimidin-4-ones as novel, reversible inhibitors of lipoprotein-associated phospholipase A2. Bioorg Med Chem Lett 2000, 10, 4, 395. |
【2】 Pinto, I.L.; Ife, R.J.; Hickey, D.M.B.; Smith, S.A.; Leach, C.A.; Porter, R.A. (SmithKline Beecham plc); Pyrimidinone cpds. and pharmaceutical compsns. containing them. EP 1028955; WO 9924420 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 38987 | 5-bromopyrimidine | 4595-59-9 | C4H3BrN2 | 详情 | 详情 |
(II) | 10164 | ethyl acrylate | 140-88-5 | C5H8O2 | 详情 | 详情 |
(III) | 38988 | ethyl (E)-3-(5-pyrimidinyl)-2-propenoate | C9H10N2O2 | 详情 | 详情 | |
(IV) | 38989 | ethyl 3-(5-pyrimidinyl)propanoate | C9H12N2O2 | 详情 | 详情 | |
(V) | 38990 | ethyl (Z)-3-hydroxy-2-(5-pyrimidinylmethyl)-2-propenoate | C10H12N2O3 | 详情 | 详情 | |
(VI) | 10180 | Thiourea | 62-56-6 | CH4N2S | 详情 | 详情 |
(VII) | 38991 | 5-(5-pyrimidinylmethyl)-2-thioxo-2,3-dihydro-4(1H)-pyrimidinone | C9H8N4OS | 详情 | 详情 |
合成路线2
该中间体在本合成路线中的序号:(II)The protected 4-pyrimidinylphenylalanine (III) was prepared by palladium-catalyzed coupling of the boronophenylalanine (I) with the 5-halopyrimidine (II). After acidic cleavage of the N-Boc protecting group of (III), the resultant amino ester (IV) was coupled with N-Boc-cycloleucine (V) to provide dipeptide (VI). Further acidic treatment of (VI) removed the N-Boc group to yield amine (VII). The chiral bromo acid (IX) was obtained by diazotization of D-valine (VIII) in the presence of HBr and KBr. Acylation of the racemic amine (VII) with bromo acid (IX) furnished the corresponding amide (X) as an epimeric mixture. The bromo group of (X) was finally displaced with potassium thioacetate to give the title thioacetate ester.
【1】 Gude, C.; Chan, K.; Firooznia, F.; et al.; Synthesis and biological activity of novel potent endothelin-converting enzyme-1 inhibitors. Bioorg Med Chem Lett 2001, 11, 3, 375. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 47701 | methyl 2-[(tert-butoxycarbonyl)amino]-3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]propanoate | C21H32BNO6 | 详情 | 详情 | |
(II) | 38987 | 5-bromopyrimidine | 4595-59-9 | C4H3BrN2 | 详情 | 详情 |
(III) | 47702 | methyl 2-[(tert-butoxycarbonyl)amino]-3-[4-(5-pyrimidinyl)phenyl]propanoate | C19H23N3O4 | 详情 | 详情 | |
(IV) | 47703 | methyl 2-amino-3-[4-(5-pyrimidinyl)phenyl]propanoate | C14H15N3O2 | 详情 | 详情 | |
(V) | 30890 | 1-[(tert-butoxycarbonyl)amino]cyclopentanecarboxylic acid | C11H19NO4 | 详情 | 详情 | |
(VI) | 47704 | methyl 2-[([1-[(tert-butoxycarbonyl)amino]cyclopentyl]carbonyl)amino]-3-[4-(5-pyrimidinyl)phenyl]propanoate | C25H32N4O5 | 详情 | 详情 | |
(VII) | 47705 | methyl 2-[[(1-aminocyclopentyl)carbonyl]amino]-3-[4-(5-pyrimidinyl)phenyl]propanoate | C20H24N4O3 | 详情 | 详情 | |
(VIII) | 21056 | (R)-(-)-Valine; D-Valine; (R)-alpha-Aminoisovaleric acid | 640-68-6 | C5H11NO2 | 详情 | 详情 |
(IX) | 33158 | (2R)-2-bromo-3-methylbutyric acid | 565-74-2 | C5H9BrO2 | 详情 | 详情 |
(X) | 47706 | methyl 2-[[(1-[[(2R)-2-bromo-3-methylbutanoyl]amino]cyclopentyl)carbonyl]amino]-3-[4-(5-pyrimidinyl)phenyl]propanoate | C25H31BrN4O4 | 详情 | 详情 |
合成路线3
该中间体在本合成路线中的序号:(I)Lithiation of 5-bromopyrimidine (I), followed by addition of CO2 produces pyrimidine-5-carboxylic acid (II). After catalytic hydrogenation of (II), the resultant tetrahydropyrimidine acid (III) is esterified with SOCl2 in MeOH to yield the corresponding methyl ester (IV). Protection of (IV) with triphenylmethyl chloride and DBU affords the N-trityl derivative (V). Then, condensation between the sodium derivative of propionamide oxime (VI) and ester (V) gives rise to the oxadiazole compound (VII). The N-trityl group of (VII) is finally removed with trifluoroacetic acid to furnish the title compound.
【1】 Dunbar, P.G.; Durant, G.J.; Fang, Z.; Abuh, Y.F.; El-Assadi, A.A.; Ngur, D.O.; Periyasamy, S.; Hoss, W.P.; Messer, W.S. Jr.; Design, synthesis, and neurochemical evaluation of 5-(3-alkyl-1,2,4-oxadiazol-5-yl)-1,4,5,6-tetrahydropyrimidines as M1 muscarinic receptor agonists. J. Med. Chem. 1993, 36, 7, 842. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 38987 | 5-bromopyrimidine | 4595-59-9 | C4H3BrN2 | 详情 | 详情 |
(II) | 61334 | 5-pyrimidinecarboxylic acid | C5H4N2O2 | 详情 | 详情 | |
(III) | 61335 | 1,4,5,6-tetrahydro-5-pyrimidinecarboxylic acid | C5H8N2O2 | 详情 | 详情 | |
(IV) | 61336 | methyl 1,4,5,6-tetrahydro-5-pyrimidinecarboxylate | C6H10N2O2 | 详情 | 详情 | |
(V) | 61337 | methyl 1-trityl-1,4,5,6-tetrahydro-5-pyrimidinecarboxylate | C25H24N2O2 | 详情 | 详情 | |
(VI) | 61338 | N'-hydroxypropanimidamide | C3H8N2O | 详情 | 详情 | |
(VII) | 61339 | 5-(3-ethyl-1,2,4-oxadiazol-5-yl)-1-trityl-1,4,5,6-tetrahydropyrimidine | C27H26N4O | 详情 | 详情 |